FAKTOR OPTIONSSCHEIN - BALCHEM CO. Stock

Certificat

DE000GX7MSQ2

Real-time BOERSE MUENCHEN 04:26:31 2024-06-03 am EDT
3.9 EUR +4.00% Intraday chart for FAKTOR OPTIONSSCHEIN - BALCHEM CO.
1 month+22.15%
3 months-16.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-03 3.9 +4.00%
24-05-31 3.75 0.00%
24-05-30 3.75 +2.74%
24-05-29 3.65 -2.93%
24-05-28 3.76 -3.09%

Real-time BOERSE MUENCHEN

Last update June 03, 2024 at 04:26 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BALCHEM CORPORATION
Issuer Goldman Sachs
WKN GX7MSQ
ISINDE000GX7MSQ2
Date issued 2022-01-18
Strike 102.4 $
Maturity Unlimited
Parity 12.29 : 1
Emission price 9.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.47
Lowest since issue 2.014
Spread 0.07
Spread %1.78%

Company Profile

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Sector
-
More about the company

Ratings for Balchem Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Balchem Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
153.6 USD
Average target price
166 USD
Spread / Average Target
+8.07%
Consensus